Stay updated on Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial

Sign up to get notified when there's something new on the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study record for Biogen’s Phase 2 PHOENIX trial of bardoxolone methyl in patients with rare chronic kidney diseases is now available. It includes trial design and results information, eligibility requirements, study locations, record dates, and supporting documents and links.
    Difference
    68%
    Check dated 2026-11-09T13:18:27.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0, while the study record remains unavailable behind a 403 Forbidden response.
    Difference
    0.2%
    Check dated 2026-11-02T12:42:22.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A notice appears at the top of the page linking to NIH transition updates and FAQs and stating that NIH is using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-26T15:45:13.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-19T15:47:01.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T16:00:56.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record with an error screen. The added 403 snippet appears at the top and the surrounding study content appears removed, indicating an access issue affecting viewing of the trial information.
    Difference
    19%
    Check dated 2026-09-21T22:36:21.000Z thumbnail image

Stay in the know with updates to Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page.